Osteonecrosis of the jaw in patient with denosumab therapy
Autor
Olate S.
Uribe F.
Martinez F.
Almeida A.
Unibazo A.
Resumen
Osteonecrosis (ON) of the jaw has previously been linked to the use of biphosphonates; however, new drugs, also shown similar conditions. This article presents a female patient with mandibular ON related to the use of denosumab. The 55-year-old presented with bone exposure with 8 months of evolution after a dental extraction. The patient began subcutaneous injections of 60 mg denosumab four months prior to the extraction and the lesion remained after the procedure. The patient, with 14 months of follow-up, show mandible ON with no favorable evolution. The clinical condition is presented and the literature of ON associated with denosumab is discussed. © 2014 E-Century Publishing Corporation. All rights reserved.
Colecciones
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Article
Tumor programmed cell death ligand 1 expression correlates with nodal metastasis in patients with cutaneous squamous cell carcinoma of the head and neck (2020)
García-Pedrero J.M.; Martínez-Camblor P.; Diaz-Coto S.; Munguia-Calzada P.; Vallina-Alvarez A.; Vazquez-Lopez F.; Rodrigo J.P.; Santos-Juanes J. (Mosby Inc., 2017) -
Article
The adverse prognostic effect of tumor budding on the evolution of cutaneous head and neck squamous cell carcinoma (2020)
Gonzalez-Guerrero M.; Martínez-Camblor P.; Vivanco B.; Fernández-Vega I.; Munguía-Calzada P.; Gonzalez-Gutierrez M.P.; Rodrigo J.P.; Galache C.; Santos-Juanes J. (Mosby Inc., 2017) -
Article
Loss of ZNF516 protein expression is related with HR-HPV infection and cervical preneoplastic lesions (2020)
Ili C.; Lopez J.; Buchegger K.; Riquelme I.; Retamal J.; Zanella L.; Mora-Lagos B.; Vivallo C.; Roa J.C.; Brebi P. (Springer Verlag, 2019)